Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT
View/ Open
Access
info:eu-repo/semantics/openAccessAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Date
2021Metadata
Show full item recordAbstract
We appreciate the comments made by Dr. Bedel et al. NLR, PLR, and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Due to this, we have listed some of the dis-orders mentioned above in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were excluded from the study. However, the presence of malignancy did not affect our results in the regression analysis.
Source
Bosnian Journal of Basic Medical SciencesVolume
21Issue
4The following license files are associated with this item: